Advertisement

Topics

Hepatitis A - Pipeline Review, H1 2015

02:29 EDT 22 Jul 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Hepatitis A - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-06-16. This 33-page report is available in PDF from $2000.

Hepatitis A - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Hepatitis A - Pipeline Review, H1 2015’, provides an overview of the Hepatitis A’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Hepatitis A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis A and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Hepatitis A
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Hepatitis A and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Hepatitis A products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Hepatitis A pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of…

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hepatitis A Overview 6
Therapeutics Development 7
Pipeline Products for Hepatitis A - Overview 7
Pipeline Products for Hepatitis A - Comparative Analysis 8
Hepatitis A - Therapeutics under Development by Companies 9
Hepatitis A - Therapeutics under Investigation by Universities/Institutes 10
Hepatitis A - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Unknown Stage Products 14
Hepatitis A - Products under Development by Companies 15
Hepatitis A - Products under Investigation by Universities/Institutes 16
Hepatitis A - Companies Involved in Therapeutics Development 17
Beijing Minhai Biotechnology Co., Ltd 17
iQur Limited 18
Zydus Cadila Healthcare Limited 19
Hepatitis A - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Combination Products 21
Assessment by Target 22
Assessment by Molecule Type 23
Drug Profiles 25
hepatitis A + hepatitis B + hepatitis E vaccine - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
hepatitis A + hepatitis B vaccine - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
hepatitis A + hepatitis B virus like particle vaccine - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
hepatitis A vaccine - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
hepatitis A vaccine - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
hepatitis A vaccine - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Hepatitis A - Dormant Projects 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 32
Disclaimer 33

For more information open Hepatitis A - Pipeline Review, H1 2015.

SKU: GMDHC6803IDB

Original Article: Hepatitis A - Pipeline Review, H1 2015

NEXT ARTICLE

More From BioPortfolio on "Hepatitis A - Pipeline Review, H1 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Hepatitis
Hepatitis (plural hepatitides) is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ. The condition can be self-limiting (healing on its own) or can progress to ...